Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) saw a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 227,100 shares, a decline of 14.9% from the August 31st total of 267,000 shares. Currently, 1.1% of the company’s shares are sold short. Based on an […]
Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) was the recipient of a large increase in short interest in August. As of August 15th, there was short interest totalling 286,200 shares, an increase of 79.0% from the July 31st total of 159,900 shares. Currently, 1.4% of the shares of the stock are sold short. Based […]
Better Therapeutics (NASDAQ:BTTX) Price Target Cut to $3 00 by Analysts at Lake Street Capital wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Better Therapeutics (BTTX) Buy Rating Reiterated at Chardan Capital modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) Chairman David P. Perry purchased 1,233,045 shares of the stock in a transaction on Thursday, July 27th. The shares were purchased at an average cost of $0.73 per share, with a total value of $900,122.85. Following the transaction, the chairman now owns 13,030,393 shares in the company, […]